Citius Pharmaceuticals (CTXR) Share-based Compensation (IS) (2022 - 2026)
Citius Pharmaceuticals (CTXR) posted Share-based Compensation (IS) of $3.81 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 24.5% from $3.06 million a year earlier and up 128.4% from the prior quarter.
Citius Pharmaceuticals (CTXR) Share-based Compensation (IS) (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation (IS) at Citius Pharmaceuticals was $11.4 million, up 14.8% year-over-year; for FY2025 (ended Sep 30, 2025), it was $10.84 million, unchanged from FY2024.
- In prior fiscal years, Citius Pharmaceuticals' Share-based Compensation (IS) was $10.84 million in FY2024 (+63.8%) and $6.62 million in FY2023.
- Quarterly Share-based Compensation (IS) has run from a low of $1.17 million in fiscal Q2 2023 to a high of $4.28 million in fiscal Q1 2026 over five years.
- On a year-over-year basis, Share-based Compensation (IS) increased in three of the last eight quarters, with growth averaging 19.8%.
- The strongest year-over-year quarter for Share-based Compensation (IS) in the past five years was fiscal Q2 2024, with growth of 164.1%; the weakest was fiscal Q3 2024, with a decline of 40.0%.
- According to Business Quant data, Share-based Compensation (IS) for the three prior fiscal quarters was $1.67 million (Q2 2026), $4.28 million (Q1 2026) and $1.64 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Citius Pharmaceuticals | 15.10 Mn | 24.39 Mn | 1.00 Mn | 3.81 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.81 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 3.06 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 3.06 Mn |
| Sep 30, 2023 | 2.29 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 1.20 Mn |
Citius Pharmaceuticals Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();